BERBEROĞLU, M. Et Al. 2006. Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.5 , 741-748.

BERBEROĞLU, M., EVLİYAOĞLU, S. O., Adiyaman, P., Ocal, G., ULUKOL, B., Simsek, F., ... ŞIKLAR, Z.(2006). Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.5, 741-748.

BERBEROĞLU, MERİH Et Al. "Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children," JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.5, 741-748, 2006

BERBEROĞLU, MERİH Et Al. "Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children." JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.5, pp.741-748, 2006

BERBEROĞLU, M. Et Al. (2006) . "Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children." JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.5, pp.741-748.

@article{article, author={MERİH BERBEROĞLU Et Al. }, title={Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children}, journal={JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM}, year=2006, pages={741-748} }